Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012
Wed, June 27, 2012
Tue, June 26, 2012
Mon, June 25, 2012

Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. annual-jmp-securities-healthcare-conference.html
Published in Health and Fitness on Friday, July 6th 2012 at 5:36 GMT by Market Wire   Print publication without navigation


Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare... -- ALISO VIEJO, Calif., July 6, 2012 /PRNewswire/ --

Avanir Pharmaceuticals To Present At The Seventh Annual JMP Securities Healthcare Conference

[ ]

ALISO VIEJO, Calif., July 6, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) today announced that company management will present an overview of the company at the Seventh Annual JMP Securities Healthcare Conference.

    • Location: The Peninsula Hotel, New York, NY
    • Presentation date: Thursday July 12, 2012
    • Presentation time: 1:00 p.m. ET

A live webcast and 30-day archive of this presentation will be available at [ http://ir.avanir.com ].

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact Ian Clements, PhD [ ir@avanir.com ] +1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ www.avanir.com ]


Publication Contributing Sources